Tag: biologic patent protection
Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Medications
Archives
Recent-posts
Managing Sleep Apnea and Respiratory Failure: CPAP vs. Oxygen Therapy
Aug, 20 2026
Debate on Banning Weight-Loss Drugs Alli and Xenical Intensifies Amid Health Concerns
Mar, 22 2024
Peppermint Oil for IBS: What the Science Says and How to Use It Right
Dec, 6 2025
IBS vs. IBD: Understanding the Difference Between Functional and Inflammatory Bowel Disorders
May, 4 2026
Breastfeeding Medication Timing: How to Reduce Infant Drug Exposure
Dec, 4 2025